Published in Am J Physiol on July 01, 1997
Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med (2001) 12.38
IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J Immunol (1998) 3.37
Innate immunity and pulmonary host defense. Immunol Rev (2000) 2.48
Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am J Physiol (1992) 2.33
Increased granulopoiesis through interleukin-17 and granulocyte colony-stimulating factor in leukocyte adhesion molecule-deficient mice. Blood (2001) 2.11
Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response. J Infect Dis (1989) 1.87
Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol (2001) 1.80
Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology (1992) 1.78
Echocardiographic diagnosis of left atrial myxoma. Am J Cardiol (1974) 1.56
Nitric oxide inhibition causes intrauterine growth retardation and hind-limb disruptions in rats. Am J Obstet Gynecol (1994) 1.55
Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model. J Clin Invest (1993) 1.53
Randomized placebo-controlled trial of amlodipine in vasospastic angina. Amlodipine Study 160 Group. J Am Coll Cardiol (1993) 1.45
Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol (1992) 1.41
Death associated with ventricular arrhythmia and thioridazine hydrochloride. JAMA (1968) 1.40
The effects of acute and chronic alcoholism on tumor necrosis factor and the inflammatory response. J Infect Dis (1989) 1.37
Acute ethanol intoxication suppresses lung chemokine production following infection with Streptococcus pneumoniae. J Infect Dis (2001) 1.20
The role of viruses in the production of heart disease. Am J Cardiol (1972) 1.18
Lipoprotein lipase activity in rat heart and adipose tissue during endotoxic shock. Am J Physiol (1980) 1.16
Nitric oxide production in experimental alcoholic liver disease in the rat: role in protection from injury. Gastroenterology (1995) 1.15
Nifedipine-associated myocardial ischemia or infarction in the treatment of hypertensive urgencies. Ann Intern Med (1987) 1.13
Severe inflammatory defect and reduced viability in CD18 and E-selectin double-mutant mice. J Clin Invest (2000) 1.12
Contribution of different organs to increased glucose consumption after endotoxin administration. J Biol Chem (1987) 1.12
Prolonged ethanol treatment enhances lipopolysaccharide/phorbol myristate acetate-induced tumor necrosis factor-alpha production in human monocytic cells. Alcohol Clin Exp Res (2001) 1.11
The cardiomyopathy of hypoparathyroidism. Another reversible form of heart muscle disease. Chest (1981) 1.10
Alcoholic cardiomyopathy. Concept of the disease and its treatment. Am J Med (1971) 1.08
Glucose kinetics and body temperature after lethal and nonlethal doses of endotoxin. Am J Physiol (1985) 1.07
Echocardiographic diagnosis of vegetative aortic bacterial endocarditis. Am J Cardiol (1974) 1.06
Ischemic cardiomyopathy. Am Heart J (1970) 1.05
Potential role of nitric oxide in a model of chronic colitis in rhesus macaques. Gastroenterology (1995) 1.05
Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor. Am J Physiol (1995) 1.03
Cardiac output and redistribution of organ blood flow in hypermetabolic sepsis. Am J Physiol (1984) 1.01
Plasma glucose concentration determines direct versus indirect liver glycogen synthesis. Am J Physiol (1986) 1.01
Granulocyte colony-stimulating factor modulates the pulmonary host response to endotoxin in the absence and presence of acute ethanol intoxication. J Infect Dis (1999) 1.01
Tumor necrosis factor increases in vivo glucose utilization of macrophage-rich tissues. Biochem Biophys Res Commun (1987) 1.00
Glutamine and fatty acid oxidation are the main sources of energy for Kupffer and endothelial cells. Am J Physiol (1991) 1.00
Antibody-mediated depletion of tumor necrosis factor-alpha impairs pulmonary host defenses to Legionella pneumophila. J Infect Dis (1997) 1.00
Activation of alveolar macrophages and lung host defenses using transfer of the interferon-gamma gene. Am J Physiol (1997) 0.98
Tumor necrosis factor-alpha in ischemia and reperfusion injury in rat lungs. J Appl Physiol (1985) (1998) 0.97
In vitro ethanol suppresses alveolar macrophage TNF-alpha during simian immunodeficiency virus infection. Am J Respir Crit Care Med (2000) 0.95
Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to action. J Hum Hypertens (2007) 0.94
Human and rat neutrophils constitutively express neural nitric oxide synthase mRNA. Nitric Oxide (1998) 0.94
Acute alcohol infusion suppresses endotoxin-induced serum tumor necrosis factor. Alcohol Clin Exp Res (1989) 0.93
Effects of ethanol on neutrophil recruitment and lung host defense in nitric oxide synthase I and nitric oxide synthase II knockout mice. Alcohol Clin Exp Res (1999) 0.92
Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failure. Am J Cardiol (1990) 0.91
Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination. Congest Heart Fail (2002) 0.89
Exogenous substrate utilization in Ca2+-tolerant myocytes from adult rat hearts. Am J Physiol (1981) 0.89
Respiratory syncytial virus and heart disease. A report of two cases. JAMA (1976) 0.88
Hyaluronic acid uptake by the isolated, perfused rat liver: an index of hepatic sinusoidal endothelial cell function. Hepatology (1993) 0.88
Sustained hypermetabolic sepsis in rats: characterization of the model. J Surg Res (1983) 0.88
Lipoprotein lipase activity in rat heart myocytes. Life Sci (1977) 0.88
Choline deficiency augments and antibody to tumor necrosis factor-alpha attenuates endotoxin-induced hepatic injury. Alcohol Clin Exp Res (1997) 0.88
In vivo glucose utilization by individual tissues during nonlethal hypermetabolic sepsis. FASEB J (1988) 0.88
Rapid induction of messenger RNA for nitric oxide synthase II in rat neutrophils in vivo by endotoxin and its suppression by prednisolone. Proc Soc Exp Biol Med (1994) 0.88
Gluconeogenic pathway in liver and muscle glycogen synthesis after exercise. J Appl Physiol (1985) (1988) 0.88
Postpartal cardiomyopathy. Cardiovasc Clin (1972) 0.88
Nitro containing L-arginine analogs interfere with assays for nitrate and nitrite. Life Sci (1995) 0.88
Increased uptake and phosphorylation of 2-deoxyglucose by skeletal muscles in endotoxin-treated rats. Am J Physiol (1987) 0.87
Cold hypersensitivity. Arch Intern Med (1974) 0.87
Anti-TNF treatment reverts increased muscle ubiquitin gene expression in tumour-bearing rats. Biochem Biophys Res Commun (1996) 0.87
Differential regulation of glucose transporter gene expression in adipose tissue or septic rats. Biochem Biophys Res Commun (1992) 0.87
Anti-tumour necrosis factor-alpha treatment interferes with changes in lipid metabolism in a tumour cachexia model. Clin Sci (Lond) (1994) 0.86
Adrenergic blockade prevents endotoxin-induced increases in glucose metabolism. Am J Physiol (1988) 0.86
Calcium antagonists: an overview. Angiology (1982) 0.86
The burden of a hot and humid environment on the heart. Mod Concepts Cardiovasc Dis (1970) 0.85
The human immunodeficiency virus type I Tat protein potentiates ethanol-induced neutrophil functional impairment in transgenic mice. Alcohol Clin Exp Res (1998) 0.85
Alcohol consumption in rats potentiates the deleterious effect of gram-negative sepsis on hepatic hyaluronan uptake. Alcohol Clin Exp Res (1993) 0.84
Importance of exogenous substrates for the energy production of adult rat heart myocytes. J Mol Cell Cardiol (1981) 0.84
Modulation of inflammation-induced changes in insulin-like growth factor (IGF)-I and IGF binding protein-1 by anti-TNF antibody. Shock (1995) 0.84
The importance of magnesium deficiency in cardiovascular disease. Am Heart J (1977) 0.84
Multiclinic controlled trial of diltiazem for Prinzmetal's angina. Am J Med (1982) 0.84
Effect of mibefradil, a T-type calcium channel blocker, on morbidity and mortality in moderate to severe congestive heart failure: the MACH-1 study. Mortality Assessment in Congestive Heart Failure Trial. Circulation (2000) 0.84
Enhancement of peritoneal leukocyte function by granulocyte colony-stimulating factor in rats with abdominal sepsis. Crit Care Med (1998) 0.83
Adrenergic blockade does not abolish elevated glucose turnover during bacterial infection. Am J Physiol (1988) 0.83
Heparin-independent release of lipoprotein lipase activity from perfused rat hearts. Biochim Biophys Acta (1983) 0.83
Acute ethanol intoxication inhibits neutrophil beta2-integrin expression in rats during endotoxemia. Alcohol Clin Exp Res (1998) 0.83
Alterations in glucose kinetics induced by pentobarbital anesthesia. Am J Physiol (1987) 0.83
Penetration of glycopeptide antibiotics in nucleus pulposus. Spine (Phila Pa 1976) (1993) 0.83
Carbohydrate dynamics in the hypermetabolic septic rat. Metabolism (1984) 0.82
Brief endotoxemia markedly increases expression of GLUT1 glucose transporter in Kupffer, hepatic endothelial and parenchymal cells. Biochem Biophys Res Commun (1993) 0.82
Alcohol-induced suppression of tumor necrosis factor--a potential risk factor for secondary infection in the acquired immunodeficiency syndrome. Prog Clin Biol Res (1990) 0.82
The effects of granulocyte colony-stimulating factor and neutrophil recruitment on the pulmonary chemokine response to intratracheal endotoxin. J Immunol (2001) 0.82
Modulation of hepatic sinusoidal endothelial cell function by Kupffer cells: an example of intercellular communication in the liver. Hepatology (1994) 0.82
The contribution of gluconeogenesis to glycogen repletion during glucose infusion in endotoxemia. Metabolism (1987) 0.82
Independent suppression of nitric oxide and TNF alpha in the lung of conscious rats by ethanol. FASEB J (1995) 0.82
Elimination of macrophages by liposome-encapsulated dichloromethylene diphosphonate suppresses the endotoxin-induced priming of Kupffer cells. J Leukoc Biol (1994) 0.82
Effects of toxic and nontoxic endotoxin derivatives on glucose kinetics. Circ Shock (1985) 0.82
Alterations in lipid and carbohydrate metabolism in sepsis. JPEN J Parenter Enteral Nutr (1989) 0.81
Lipoprotein lipase-suppressing mediator in serum of endotoxin-treated rats. Am J Physiol (1986) 0.81
Effect of granulocyte colony-stimulating factor on sepsis-induced changes in neutrophil accumulation and organ glucose uptake. J Infect Dis (1992) 0.81
Anti-TNF treatment does not reverse the abnormalities in lipid metabolism of the obese Zucker rat. Am J Physiol (1997) 0.81
Tumor necrosis factor mediates zymosan-induced increase in glucose flux and insulin resistance. Am J Physiol (1995) 0.81
Effects of NO synthase inhibitors, arginine-deficient diet, and amiloride in pregnant rats. Am J Physiol (1997) 0.81
Importance of hyperglucagonemia in eliciting the sepsis-induced increase in glucose production. Circ Shock (1989) 0.81
Ouabain enhances basal release of nitric oxide from carotid artery. Am J Med Sci (1993) 0.81
Cardiopulmonary pharmacology of enkephalins in the conscious dog. Peptides (1981) 0.81
Ethanol suppression of the functional state of polymorphonuclear leukocytes obtained from uninfected and simian immunodeficiency virus infected rhesus macaques. Alcohol Clin Exp Res (1999) 0.81
Heart failure in diabetes mellitus: causal and treatment considerations. Minerva Cardioangiol (2004) 0.80
Chronic alcohol administration stimulates nitric oxide formation in the rat liver with or without pretreatment by lipopolysaccharide. Alcohol Clin Exp Res (1995) 0.80
Modulation of the lung host response by granulocyte colony-stimulating factor in rats challenged with intrapulmonary endotoxin. Shock (1997) 0.80
Short-term effects of intravenous clonidine in congestive heart failure. Clin Pharmacol Ther (1981) 0.80